Yes, Su Chenyu wants not only a giant in the biomedical industry, but also the entire biomedical era in the future.

Therefore, for Ginkgo Fund, and even for Su Chenyu, whether it is Amgen or Genentech, it is just the beginning. In Su Chenyu's future planning, Ginkgo Fund, as the representative of the SS consortium in the biomedical industry, must also make a scene here.

Besides, the biomedical industry is such a sunrise industry, as long as human beings exist, this industry will never be outdated and outdated, after all, the human body can never avoid birth, old age, sickness and death. Therefore, Su Chenyu will make such a great effort to engage in the biomedical industry, once the layout is completed here, the profits he can create for himself are far more terrible than Internet companies.

Among other things, to take the simplest example, Amgen's most successful biotech drug, EPO, brings in billions of dollars a year in overseas markets alone. Therefore, the first thing Su Chenyu did after acquiring Amgen and Genentech and merging them was to take back the overseas sales rights of EPO from Johnson & Johnson.

However, there is no doubt that in the face of such a "golden rooster" that "lays golden eggs", Johnson & Johnson will be a ghost if it can agree to let go. In the face of the huge Johnson & Johnson company, Su Chenyu and the SS consortium are not helpless, but it is really not worth the local fight because of this matter. After all, the days ahead are still very long, let's come to the future, don't look at your kid today, you will feel good in the future.

Besides, now is a good time for the SS Consortium and Ginkgo Fund to enter the biomedical industry in a big way, and we can't stop because of this small thing. You know, now is the era when biotechnology is just starting, so many biomedical companies are still in the "seedling" stage. For this kind of "little seedling" in the era of biomedicine, there is no need to do more, just smash it with US dollars.

However, the "little seedlings" are "little seedlings" after all - not the top thing, if the Ginkgo Fund wants to dominate the entire biomedical industry as soon as possible, then the most effective way is to attack those giants. After all, the strength of these giants is very strong in their own right, and after directly serving them to a nest, they will take it as "the power of impromptu combat".

Besides, what's the point of just starting a small company, or is it interesting to engage in those giants? Yes, although Amgen and Genentech will be biomedical giants in the future, but now they all belong to small roles like "Song Bingjia" and "Song Bingyi" - there is no difficulty and sense of accomplishment in engaging them at all, okay?

Therefore, Su Chenyu decided to make a big wave, and he already had a goal in mind, this goal......

As soon as this news was exposed, not only the entire biomedical industry was blown up, but even the entire Wall Street was completely stunned -- it was impossible to figure out what the Ginkgo Fund and the super dad behind him, SS Financial Holdings, were going to do? Or was the other party crazy?—— or just crazy.

When the Wall Street Journal broke the news that Ginkgo Fund had agreed to buy Johnson & Johnson at a sky-high price of $41.5 billion, everyone thought it was fake news — yes, it was definitely fake news.

Damn, this news is really a nuclear bomb, and it directly blew up countless people, who can tell me, what the hell is this?

$41.5 billion? Not $415 million, not $4.15 billion, but $41.5 billion -- that's really sky-high. You know, this is not the era when the dollar is worthless in the future, $41.5 billion, according to the rate of inflation, is about worth more than $150 billion in the future.

The point is, not only that, although the price is amazing, but who made Johnson & Johnson a super biomedical giant, the market value of the family itself is as high as nearly 30 billion US dollars.

But who can tell me that a supergiant like Johnson & Johnson has become someone else's meal, what the hell is this?

Obviously, this is absolutely fake news, yes, it is especially fake news - this is the thoughts and thoughts of countless people!

Hehe, soon, everyone knows that he is really too young and naïve, and this world is really too dangerous, and he doesn't know these routines that others play.

Because, soon after, this news was confirmed by Ginkgo Fund, they did launch a sky-high $41.5 billion super merger and acquisition case to Johnson & Johnson, in order to wholly control the international biomedical giant. Moreover, not long after Ginkgo Fund came forward to confirm the matter, the board of directors of Johnson & Johnson officially announced to the outside that the company had indeed received an offer from Ginkgo Fund, and the company was studying the rationality and feasibility of the matter.

I went to my mother's house, and it wasn't fake news, or a joke, but it was true.

The most important thing is that the two parties of Ginkgo Fund and Johnson & Johnson seem to have a special posture of being affectionate and concubines, and they can't really succeed. Your mother kisses, in this way, the strength and power of the SS consortium in the biomedical industry will increase dramatically, and it will become a real supergiant in one fell swoop.

Not only that, Johnson & Johnson is involved in not only the biomedical industry, but also the chemical industry and other industries, so it will directly form a confrontation with the DuPont consortium - this is definitely the last thing the DuPont family wants to see.

Therefore, the DuPont family decided to intervene in the final decision to influence Johnson & Johnson, after all, once the hungry wolf of the SS consortium ate Johnson & Johnson, the "big supplement". With Johnson & Johnson's technology and strength, coupled with the terrifyingly large financial support of the SS consortium, then no one else will have a good life. Moreover, the most important thing is that once the SS consortium tastes the super sweetness of the chemical industry, then why is it worth it? The absolute force is to rush in on a large scale, and even if the DuPont consortium resists desperately, it is estimated that it will not be able to resist the penetration of the other party - this is the power of capital.

Therefore, the best thing to do is to cut off the idea of the SS consortium from the roots, so the board of directors of Johnson & Johnson must veto the proposal. For this matter, the DuPont consortium can still easily do it, after all, they still have a few close board members at Johnson & Johnson!

Without any surprise, Johnson & Johnson ultimately vetoed the $41.5 billion merger deal with Ginkgo Fund. When the news came out, no one felt any surprise, simply because in the eyes of many people - this is a superfluous thing, it is simply impossible.

Therefore, when Johnson & Johnson officially responded to Ginkgo Fund and refused the acquisition offer, everyone looked like a matter of course. Moreover, many people think that Ginkgo Biloba Fund is humiliating itself, even if it is "flirting", you have to look at the object - can a giant like Johnson & Johnson flirt casually? It's really naïve!

Hehe, this group of stupid earthlings still don't understand the bad nature of the Ginkgo Fund and the SS consortium behind it. However, soon, they will soon see who makes the local tyrant rich and what is shameless!

Just after Johnson & Johnson officially rejected the acquisition invitation of Ginkgo Fund, before everyone could react, Ginkgo Fund began to make crazy flirts again!

This side just finished teasing Johnson & Johnson, but it didn't work, and that side immediately hooked up with Roche Pharmaceutical. Soon, Ginkgo Fund announced that it officially launched a friendly acquisition invitation to Roche Pharmaceuticals at a sky-high price of 38.3 billion US dollars!

, many people are really shocked by their eyeballs now, how is this?—— just finished teasing Johnson & Johnson, and now they are going to tease Roche Pharmaceutical-is this special money to burn?

However, this time, Roche Pharmaceutical is also very sick, and it is actually the same as Johnson & Johnson, where it is actually eyebrow-to-eye with Ginkgo Fund-just ask you if you want to be ashamed? Anyway, you are also a century-old pharmaceutical giant!

Roche Pharmaceutical's performance is even more shameless than Johnson & Johnson, and their chairman and many management have expressed their welcome to cooperate with Ginkgo Fund, mainly to express their joy at joining the big family of SS Consortium!

In the face of this kind of "shameless" thing, the DuPont consortium really can't stand it, can you be more reserved! Boy, you are still too young, the DuPont consortium is repeating its old tricks again and putting pressure on the shareholders behind Roche Pharmaceutical.

Not to mention, the brand of the DuPont consortium is still quite hard, and the group of coerced shareholders of Roche Pharmaceutical really admit it. Although the chairman of Roche Pharmaceutical explained the value of the acquisition of Ginkgo Fund, it was useless, and the major shareholders finally rejected the merger and acquisition.

Hehe, once again let everyone watch a good show - Ginkgo Fund, a local tyrant wielding US dollars, was rejected again - I have to say, this is really the news of Xi Da Puben!

However, although it has been rejected by Johnson & Johnson and Roche Pharmaceuticals one after another, Ginkgo Fund doesn't seem to care at all, or rather, there is no shame at all!

After being rejected by Roche Pharmaceutical again, Ginkgo Fund not only did not restrain its "flirtation", but continued to shamelessly "flirt"!

$18.9 billion in a bona fide takeover of GlaxoSmithKline and rejected, $21.3 billion in a bona fide takeover from Merck and Co., Ltd., rejected......

From beginning to end, all the acquisitions of Ginkgo Fund failed, and they were fiasco, and they were rejected by the target companies.

Isn't it tragic?

Hehe, it's pretty miserable!

However......